Picture, if you will, a cancer cell. Alone, it is just a harmless anomaly. But free to divide exponentially, the cells explode to take over an organ. There's nothing like cancer to show the sheer power of multiplication.
Now imagine that instead of cancer cells, you have two UVM Cancer Center members, a basic researcher and a clinician, each working away in their own areas. The two decide to collaborate, combining the researcher’s lab work and the physician’s knowledge of the patient care dimension of the disease. With this doubled-up approach, they are able to tackle with their own focused and multiplied power some of the biggest questions in cancer today. This, in essence, is the heart of what is known as “translational research.”
Read this article recently published in Vermont Medicine about research collaborations.